Professor of Psychiatry, Neurology, and Neuroscience University of Cincinnati College of Medicine Cincinnati, OhioCurrent Psychiatry Neurocognitive symptoms are a prominent feature of nearly all neurodegenerative dementias. The domains included for consideration are attention, memory, executive func. tion, language, and socioemotional development Neurocognitive assessment (NA) is now widely used in the screening and diagnostic process of cognitive disorders, and NA is commonly thought in terms of the standardized neuropsychological tests used to measure cognitive abilities and deficits Abstract. In this chapter, we describe general issues in psychological assessment of neurocognitive disorders in older adults and demonstrate using specific examples of self-report, informant report, and performance-based measures, and we also describe the recent emergence of unobtrusive means of assessing cognition and function Mini-Cog (PDF) Memory Impairment Screen (PDF) Informant tools (family members and close friends) Eight-item Informant Interview to Differentiate Aging and Dementia (AD8) , · Neurocognitive assessments in people with IDD can be a complex process and should be conducted by professionals with relevant expertise. Their goal is to promote proficiency and expertise in assessing dementia and age related cognitive line in clinical practice The goal of this review is to identify alternative measures for possible inclusion in future clinical trials and interventions evaluating early neurocognitive development. Specialized assessment of memory, executive functions, language, and DSMintroduces the neurocognitive disorders category as a continuum of cognitive line spanning from mild neurocognitive disorder, or preclinical dementia, to major B.* Conduct brief structured assessment Patient assessment: Mini-Cog or GPCOG Informant assessment of patient: Short IQCODE, AD8 or GPCOG Signs/symptoms present Informant available to confirm Follow-up during subsequent AWV Brief assesment(s) triggers concerns: Patient: Mini-Cog ≤3 or GPCOG <5 (score is indeterminate without mild neurocognitive disorder and major neurocognitive disorder, the broader research and practice literature typically uses the terms mild cognitive impairment and dementia, and this document follows that convention. The assessment Henry A. Nasrallah, MD, DLFAPA.
Professor of Psychiatry, Neurology, and Neuroscience University of Cincinnati College of Medicine Cincinnati, OhioCurrent Psychiatry Neurocognitive symptoms are a prominent feature of nearly all neurodegenerative dementias. The domains included for consideration are attention, memory, executive func. tion, language, and socioemotional development Neurocognitive assessment (NA) is now widely used in the screening and diagnostic process of cognitive disorders, and NA is commonly thought in terms of the standardized neuropsychological tests used to measure cognitive abilities and deficits Abstract. In this chapter, we describe general issues in psychological assessment of neurocognitive disorders in older adults and demonstrate using specific examples of self-report, informant report, and performance-based measures, and we also describe the recent emergence of unobtrusive means of assessing cognition and function Mini-Cog (PDF) Memory Impairment Screen (PDF) Informant tools (family members and close friends) Eight-item Informant Interview to Differentiate Aging and Dementia (AD8) , · Neurocognitive assessments in people with IDD can be a complex process and should be conducted by professionals with relevant expertise. Their goal is to promote proficiency and expertise in assessing dementia and age related cognitive line in clinical practice The goal of this review is to identify alternative measures for possible inclusion in future clinical trials and interventions evaluating early neurocognitive development. Specialized assessment of memory, executive functions, language, and DSMintroduces the neurocognitive disorders category as a continuum of cognitive line spanning from mild neurocognitive disorder, or preclinical dementia, to major B.* Conduct brief structured assessment Patient assessment: Mini-Cog or GPCOG Informant assessment of patient: Short IQCODE, AD8 or GPCOG Signs/symptoms present Informant available to confirm Follow-up during subsequent AWV Brief assesment(s) triggers concerns: Patient: Mini-Cog ≤3 or GPCOG <5 (score is indeterminate without mild neurocognitive disorder and major neurocognitive disorder, the broader research and practice literature typically uses the terms mild cognitive impairment and dementia, and this document follows that convention. The assessment Henry A. Nasrallah, MD, DLFAPA.
Français
English
Deutsch
Español
Italiano
Português